Review



oxygen-delivery nanoparticles cmpf  (BioMimetic Therapeutics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioMimetic Therapeutics oxygen-delivery nanoparticles cmpf
    Illustration of the biomimetic oxygen-delivery <t>nanoparticles</t> (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1
    Oxygen Delivery Nanoparticles Cmpf, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oxygen-delivery+nanoparticles+cmpf/oxygen+delivery+nanoparticles/pmc11887188-25-5-5
    Average 90 stars, based on 1 article reviews
    oxygen-delivery nanoparticles cmpf - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors"

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors

    Journal: Journal of Nanobiotechnology

    doi: 10.1186/s12951-025-03257-6

    Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1
    Figure Legend Snippet: Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1

    Techniques Used: Concentration Assay, Activation Assay, Positron Emission Tomography-Computed Tomography, Imaging, In Vivo, Injection, Drug discovery, Membrane, Positron Emission Tomography, Computed Tomography

    Related Articles

    Concentration Assay:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Activation Assay:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Positron Emission Tomography-Computed Tomography:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Imaging:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    In Vivo:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Injection:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Drug discovery:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Membrane:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Positron Emission Tomography:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Computed Tomography:

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.
    Article Snippet: Having verified the oxygenation of CmPF on the cellular level, we set out to confirm whether the activation of Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.



    Similar Products

    oxygen-delivery nanoparticles cmpf  (BioMimetic Therapeutics)
    90
    BioMimetic Therapeutics oxygen-delivery nanoparticles cmpf
    Illustration of the biomimetic oxygen-delivery <t>nanoparticles</t> (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1
    Oxygen Delivery Nanoparticles Cmpf, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oxygen-delivery+nanoparticles+cmpf/oxygen+delivery+nanoparticles/pmc11887188-25-5-5
    Average 90 stars, based on 1 article reviews
    oxygen-delivery nanoparticles cmpf - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1

    Journal: Journal of Nanobiotechnology

    Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors

    doi: 10.1186/s12951-025-03257-6

    Figure Lengend Snippet: Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1

    Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

    Techniques: Concentration Assay, Activation Assay, Positron Emission Tomography-Computed Tomography, Imaging, In Vivo, Injection, Drug discovery, Membrane, Positron Emission Tomography, Computed Tomography